Picture BIO Deutschland German Corona Special 2021 Digital 650x80px
Financing › Details

Pharvaris–SEVERAL: investment, 201601 financing round Series A €15m from LSP + Kurma Partners + Idinvest Partners


Period Period 2016-01-01
  Successor Pharvaris–SEVERAL: investment, 201909 financing round Series B $66m led by Foresite Capital
Organisations Money taker Pharvaris B.V.
  Money source SEVERAL
Products Product PHA121 (incl in soft capsules as PHVS416) (Pharvaris)
  Product 2 venture capital

Record changed: 2019-09-23


Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Pharvaris B.V.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Berlin Partner Network in German Capital Region 650x80px

» top